VANDA PHARMACEUTICALS INC. (VNDA) Free cash flow 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$110.4MFY2025 · since FY2016: -$9.5M → -$110.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$110.4M | -579.8% |
| FY2024 | -$16.2M | -230.8% |
| FY2023 | $12.4M | -60.3% |
| FY2022 | $31.3M | -50.8% |
| FY2021 | $63.7M | +27.4% |
| FY2020 | $50.0M | +11.2% |
| FY2019 | $44.9M | +51.7% |
| FY2018 | $29.6M | +912.1% |
| FY2017 | -$3.6M | +61.7% |
| FY2016 | -$9.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice